FRESENIUS MEDICAL CARE AG Interest Expense
FRESENIUS MEDICAL CARE AG (FMS) reported Interest Expense of EUR 375.22 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-24.
Financial Statements › Expense Statement › Interest Expense
ifrs-full:InterestExpense · last filed 2026-02-24
- FRESENIUS MEDICAL CARE AG interest expense for the quarter ending 2019-12-31 was 159.11M EUR, a 18.15% decline year-over-year.
- FRESENIUS MEDICAL CARE AG interest expense for the quarter ending 2019-09-30 was 104.72M EUR, a 37.96% increase year-over-year.
- FRESENIUS MEDICAL CARE AG interest expense for the quarter ending 2019-06-30 was 114.36M EUR.
- FRESENIUS MEDICAL CARE AG interest expense for the quarter ending 2019-03-31 was -107.85M EUR.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 375.22M EUR 20-F · filed 2026-02-24 | |||||||
| 2024-12-31 | 393.32M EUR 20-F · filed 2026-02-24 | |||||||
| 2023-12-31 | 420.90M EUR 20-F · filed 2025-02-25 | |||||||
| 2022-12-31 | 359.00M EUR 20-F · filed 2024-02-20 | |||||||
| 2021-12-31 | 343.81M EUR 20-F · filed 2023-02-22 | |||||||
| 2020-12-31 | 407.06M EUR 20-F · filed 2022-02-22 | |||||||
| 2019-12-31 | 159.11M EUR derived: 20-F 12 month − 6-K 9 month · filed 2021-02-23 | 263.84M EUR derived: sum of 2 quarters · filed 2021-02-23 | 378.19M EUR derived: sum of 3 quarters · filed 2021-02-23 | 486.04M EUR 20-F · filed 2021-02-23 | ||||
| 2019-09-30 | 104.72M EUR 6-K · filed 2019-10-31 | 219.08M EUR derived: sum of 2 quarters · filed 2019-10-31 | 326.93M EUR 6-K · filed 2019-10-31 | 305.64M EUR derived: sum of 4 quarters · filed 2020-02-20 | ||||
| 2019-06-30 | 114.36M EUR 6-K · filed 2019-07-30 | 222.20M EUR 6-K · filed 2019-07-30 | 200.91M EUR derived: sum of 3 quarters · filed 2020-02-20 | 276.82M EUR derived: sum of 4 quarters · filed 2020-02-20 | ||||
| 2019-03-31 | -107.85M EUR 6-K · filed 2019-05-02 | 86.56M EUR derived: sum of 2 quarters · filed 2020-02-20 | 162.47M EUR derived: sum of 3 quarters · filed 2020-02-20 | 77.76M EUR derived: sum of 4 quarters · filed 2020-02-20 | ||||
| 2018-12-31 | 194.41M EUR derived: 20-F 12 month − 6-K 9 month · filed 2020-02-20 | 270.32M EUR derived: sum of 2 quarters · filed 2020-02-20 | 185.61M EUR derived: sum of 3 quarters · filed 2020-02-20 | 437.96M EUR 20-F · filed 2020-02-20 | -301.06M EUR 20-F · filed 2019-02-20 | |||
| 2018-09-30 | 75.91M EUR 6-K · filed 2019-10-31 | -74.45M EUR 6-K · filed 2018-10-30 | -8.80M EUR derived: sum of 2 quarters · filed 2019-10-31 | 243.55M EUR 6-K · filed 2019-10-31 | -238.72M EUR 6-K · filed 2018-10-30 | -182.75M EUR derived: sum of 4 quarters · filed 2019-10-31 | ||
| 2018-06-30 | -84.71M EUR 6-K · filed 2019-07-30 | -84.30M EUR 6-K · filed 2018-08-01 | -167.64M EUR 6-K · filed 2019-07-30 | -164.27M EUR 6-K · filed 2018-08-01 | -258.66M EUR derived: sum of 3 quarters · filed 2019-07-30 | -344.77M EUR derived: sum of 4 quarters · filed 2019-07-30 | ||
| 2018-03-31 | -82.93M EUR 6-K · filed 2019-05-02 | -79.98M EUR 6-K · filed 2018-05-03 | -173.95M EUR derived: sum of 2 quarters · filed 2019-05-02 | -260.06M EUR derived: sum of 3 quarters · filed 2019-05-02 | -355.03M EUR derived: sum of 4 quarters · filed 2019-05-02 | |||
| 2017-12-31 | -91.02M EUR derived: 20-F 12 month − 6-K 9 month · filed 2019-02-20 | -177.13M EUR derived: sum of 2 quarters · filed 2019-02-20 | -272.10M EUR derived: sum of 3 quarters · filed 2019-02-20 | -364.82M EUR 20-F · filed 2019-02-20 | ||||
| 2017-09-30 | -86.11M EUR 6-K · filed 2018-10-30 | -181.08M EUR derived: sum of 2 quarters · filed 2018-10-30 | -273.81M EUR 6-K · filed 2018-10-30 | |||||
| 2017-06-30 | -94.97M EUR 6-K · filed 2018-08-01 | -187.69M EUR 6-K · filed 2018-08-01 | ||||||
| 2017-03-31 | -92.73M EUR 6-K · filed 2018-05-03 | |||||||
| 2016-12-31 | -363.41M EUR 20-F · filed 2019-02-20 |